Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia

International Journal of Hematology

Volumn 101, Issue 1, 2015, Pages 23-31

  Massa, Margherita ^a   Canzonieri, Cecilia ^b   Campanelli, Rita ^a   Ornati, Federica ^a   Fois, Gabriela ^a   Pagella, Fabio ^a   Matti, Elina ^a   Buscarini, Elisabetta ^c   Danesino, Cesare ^b   Rosti, Vittorio ^a   Olivieri, Carla ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c MAGGIORE HOSPITAL   (Italy)

Author keywords

ACVRL1; CD34+CD133+VEGFR 2 cells; CD34+VEGFR 2+ cells; Circulating CD34+ cell; ENG; Hereditary Hemorrhagic Telangiectasia

Indexed keywords

ACTIVIN RECEPTOR LIKE KINASE 1; CD133 ANTIGEN; CD34 ANTIGEN; GENOMIC DNA; SMAD4 PROTEIN; VASCULOTROPIN RECEPTOR 2; ACTIVIN RECEPTOR 2; ACVRL1 PROTEIN, HUMAN; BIOLOGICAL MARKER; CELL SURFACE RECEPTOR; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ACVRL1 GENE; ADOLESCENT; ADULT; AGED; ARTICLE; CD34 SELECTION; CELL MATURATION; CELL METABOLISM; CELL MOTILITY; CELL SUBPOPULATION; CHILD; CONTROLLED STUDY; CYTOFLUOROMETRY; DISEASE DURATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; ENG GENE; FEMALE; GENE; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; NONSENSE MUTATION; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RENDU OSLER WEBER DISEASE; STEM CELL MOBILIZATION; STOP CODON; AGE; BLOOD; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED; MUTATION; ONSET AGE; PATHOLOGY; PHENOTYPE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; VERY ELDERLY; YOUNG ADULT;

ACTIVIN RECEPTORS, TYPE II; ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; ENDOTHELIAL CELLS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RECEPTORS, CELL SURFACE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 84925498905     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-014-1698-4     Document Type: Article

References (31)

1. Faughnan M, Palda V, Garcia-Tsao G, Geisthoff U, McDonald J, Proctor D, Spears J, Brown D, Buscarini E, Chesnutt M, Cottin V, Ganguly A, Gossage J, Guttmacher A, Hyland R, Kennedy S, Korzenik J, Mager J, Ozanne A, Piccirillo J, Picus D, Plauchu H, Porteous M, Pyeritz R, Ross D, Sabba C, Swanson K, Terry P, Wallace M, Westermann C, White R, Young L, Zarrabeitia R. International guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet. 2011;48:73–87.
2. Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010;24:203–19.
3. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17:860–71.
4. Lesca G, Genin E, Blachier C, Olivieri C, Coulet F, Brunet G, Dupuis-Girod S, Buscarini E, Soubrier F, Calender A, Danesino C, Giraud S, Plauchu H, Network F-IH. Hereditary hemorrhagic telangiectasia: evidence for regional founder effects of ACVRL1 mutations in French and Italian patients. Eur J Hum Genet. 2008;16:742–9.
5. Lesca G, Olivieri C, Burnichon N, Pagella F, Carette MF, Gilbert-Dussardier B, Goizet C, Roume J, Rabilloud M, Saurin JC, Cottin V, Honnorat J, Coulet F, Giraud S, Calender A, Danesino C, Buscarini E, Plauchu H, Network F–I–R–O. Genotype–phenotype correlations in hereditary hemorrhagic telangiectasia: data from the French–Italian HHT network. Genet Med. 2007;9:14–22.
6. Gallione C, Scheessele E, Reinhardt D, Duits A, Berg J, Westermann C, Marchuk D. Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in The Netherlands antilles: evidence for a founder effect. Hum Genet. 2000;107:40–4.
7. Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu–Osler–Weber syndrome). Am J Med Genet. 2000;91:66–7.
8. McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al. Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345–51.
9. Johnson DW, Berg JN, Baldwin MA, Gallione CJ, Marondel I, Yoon SJ, Stenzel TT, Speer M, Pericak-Vance MA, Diamond A, Guttmacher AE, Jackson CE, Attisano L, Kucherlapati R, Porteous ME, Marchuk DA. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat Genet. 1996;13:189–95.
10. Trembath R, Thomson J, Machado R, Morgan N, Atkinson C, Winship I, Simonneau G, Galie N, Loyd J, Humbert M, Nichols W, Morrell N, Berg J, Manes A, McGaughran J, Pauciulo M, Wheeler L. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2001;345:325–34.
11. Olivieri C, Lanzarini L, Pagella F, Semino L, Corno S, Valacca C, Plauchu H, Lesca G, Barthelet M, Buscarini E, Danesino C. Echocardiographic screening discloses increased values of pulmonary artery systolic pressure in 9 of 68 unselected patients affected with hereditary hemorrhagic telangiectasia. Genet Med. 2006;8:183–90.
12. Gallione CJ, Repetto GM, Legius E, Rustgi AK, Schelley SL, Tejpar S, Mitchell G, Drouin E, Westermann CJ, Marchuk DA. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852–9.
13. Cole SG, Begbie ME, Wallace GM, Shovlin CL. A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577–82.
14. Bayrak-Toydemir P, McDonald J, Akarsu N, Toydemir RM, Calderon F, Tuncali T, Tang W, Miller F, Mao R. A fourth locus for hereditary hemorrhagic telangiectasia maps to chromosome 7. Am J Med Genet A. 2006;140:2155–62.
15. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood. 2007;109:1953–61.
16. Fu Y, Chang A, Chang L, Niessen K, Eapen S, Setiadi A, Karsan A. Differential regulation of transforming growth factor beta signaling pathways by notch in human endothelial cells. J Biol Chem. 2009;284:19452–62.
17. Lebrin F, Srun S, Raymond K, Martin S, van den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med. 2010;16:420–8.
18. Fernandez-L A, Sanz-Rodriguez F, Zarrabeitia R, Pérez-Molino A, Hebbel R, Nguyen J, Bernabéu C, Botella L. Blood outgrowth endothelial cells from hereditary haemorrhagic telangiectasia patients reveal abnormalities compatible with vascular lesions. Cardiovasc Res. 2005;68:235–48.
19. Zucco L, Zhang Q, Kuliszewski MA, Kandic I, Faughnan ME, Stewart DJ, Kutryk MJ. Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia. PLoS One. 2014;9:e89927.
20. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109:1801–9.
21. Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med. 2012;2:a006692.
22. + cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol. 2007;35:1109–18.
23. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Böhm M, Nickenig G. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999–1007.
24. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood. 2000;95:952–8.
25. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R, Group HHTFI-GW. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011;48:73–87.
26. Olivieri C, Pagella F, Semino L, Lanzarini L, Valacca C, Pilotto A, Corno S, Scappaticci S, Manfredi G, Buscarini E, Danesino C. Analysis of eng and ACVRL1 genes in 137 HHT italian families identifies 76 different mutations (24 novel). Comparison with other European studies. J Hum Genet. 2007;52:820–9.
27. Prater DN, Case J, Ingram DA, Yoder MC. Working hypothesis to redefine endothelial progenitor cells. Leukemia. 2007;21:1141–9.
28. Borges L, Iacovino M, Mayerhofer T, Koyano-Nakagawa N, Baik J, Garry DJ, Kyba M, Letarte M, Perlingeiro RC. A critical role for endoglin in the emergence of blood during embryonic development. Blood. 2012;119:5417–28.
29. Chen CZ, Li M, de Graaf D, Monti S, Göttgens B, Sanchez MJ, Lander ES, Golub TR, Green AR, Lodish HF. Identification of endoglin as a functional marker that defines long-term repopulating hematopoietic stem cells. Proc Natl Acad Sci USA. 2002;99:15468–73.
30. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, Salmon M. Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial t cells contributes to their accumulation within the rheumatoid synovium. J Immunol. 2000;165:3423–9.
31. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, Simm A. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2003;42:2073–80.